ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/19/2026
Back to search
Official data from USPTO
NEUROCRINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEUROCRINE
ST13
US500000098975517Class
5, 44
Filing
98975517
Registration
7690781
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
08/19/2026
Trademark type
Word
Nice classes
5, 44
Filing date
09/21/2023
Registration date
02/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/11/2025
Last transaction
08/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/01/2024
First use in commerce
02/01/2024
Drawing code
4
Owner type
03
Owner location
San Diego, CA, US
Examiner
CHUO, EMILY M
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
Neurocrine Biosciences, Inc.
Representatives
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment of Huntington's Diseasechorea associated with Huntington's Disease
Class 44
Providing medical information; Providing medical information in the field of endocrinehormonalgenetic diseasesdisordersconditions; providing medical information in the field of psychiatricneurologicalcentral nervous systemmovement diseasesdisordersconditions; Providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease
Publications
History of USPTO decisions and trademark events.
34 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/20/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/20/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/20/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/20/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/20/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/30/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/30/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/30/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/18/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/18/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/17/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
01/17/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2024
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
12/09/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/04/2024
IUAF
USE AMENDMENT FILED
09/24/2024
DRRR
DIVISIONAL REQUEST RECEIVED
09/24/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/24/2024
EISU
TEAS STATEMENT OF USE RECEIVED
09/24/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/23/2024
EX1G
SOU EXTENSION 1 GRANTED
08/23/2024
EXT1
SOU EXTENSION 1 FILED
08/23/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/23/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/18/2024
PUBO
PUBLISHED FOR OPPOSITION
06/18/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/29/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2024
DOCK
ASSIGNED TO EXAMINER
05/15/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2023
NWAP
NEW APPLICATION ENTERED
09/25/2023
Continuous trademark protection
Get notified about every new filing that threatens NEUROCRINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.